Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FJR47
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,731
Award facts
- Contract value 100% obligated
- $28,730.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,730.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle extending through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through this expansive contract, which enables the company to supply a diverse portfolio of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. RINVOQ ER (upadacitinib extended-release) is a prescription medication used in rheumatoid arthritis treatment, consistent with the company's role supplying specialized pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FJR47?
SPE2DB25FJR47 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FJR47 worth?
The government has obligated $28,731 on SPE2DB25FJR47.
Is contract SPE2DB25FJR47 an order under another contract?
Yes. SPE2DB25FJR47 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJR47 competed?
The extent of competition for SPE2DB25FJR47 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award